Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 September 2004, Vol. 104, No. 6, pp. 1648-1655.
Prepublished online as a Blood First Edition Paper on June 3, 2004; DOI 10.1182/blood-2004-02-0448.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-02-0448v1
104/6/1648    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hess, D. A
Right arrow Articles by Nolta, J. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hess, D. A
Right arrow Articles by Nolta, J. A
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted February 9, 2004
Accepted April 15, 2004

Functional characterization of highly purified human hematopoietic repopulating cells isolated based on aldehyde dehydrogenase activity

David A Hess*, Todd E Meyerrose, Louisa Wirthlin, Timothy P Craft, Phillip E Herrbrich, Michael H Creer, and Jan A Nolta

Internal Medicine, Division of Oncology, Hematopoietic Development and Malignancy Program, Washington University School of Medicine, St. Louis, MO, USA
Pathology and Laboratory Medicine, Saint Louis University, St. Louis, MO, USA

* Corresponding author; email: dhess{at}im.wustl.edu.

Human hematopoietic stem cells (HSC) are commonly purified by the expression of cell surface markers such as CD34. Since cell phenotype can be altered by cell cycle progression or ex vivo culture, purification based on conserved stem cell function may represent a more reliable way to isolate various stem cell populations. We have purified primitive HSC from human umbilical cord blood (UCB) by lineage depletion (Lin-) followed by selection of cells with high aldehyde dehydrogenase (ALDH) activity. ALDHhiLin- cells comprised 22.6±3.0% of the Lin- population, and highly co-expressed primitive HSC phenotypes (CD34+CD38- and CD34+CD133+). In vitro hematopoietic progenitor function was enriched in the ALDHhiLin- population, compared to ALDHloLin- cells. Multilineage human hematopoietic repopulation was observed exclusively after transplantation of ALDHhiLin- cells. Direct comparison of repopulation using the NOD/SCID and NOD/SCID {beta}2 microglobulin ({beta}2M) null models demonstrated that 10-fold greater numbers of ALDHhiLin- cells were needed to engraft the NOD/SCID mouse as compared to the more permissive NOD/SCID {beta}2M null mouse, suggesting that the ALDHhiLin- population contained committed progenitors as well as primitive repopulating cells. Cell fractionation based on lineage depletion and ALDH activity provides a viable and prospective purification of HSC based on cell function rather than cell surface phenotype.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Vitamin A metabolism and stemness
Edward F. Srour
Blood 2004 104: 1597-1598. [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
B. J. Capoccia, D. L. Robson, K. D. Levac, D. J. Maxwell, S. A. Hohm, M. J. Neelamkavil, G. I. Bell, A. Xenocostas, D. C. Link, D. Piwnica-Worms, et al.
Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity
Blood, May 21, 2009; 113(21): 5340 - 5351.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Yokota, H. Takeuchi, N. Maeda, Y. Ohoka, C. Kato, S.-Y. Song, and M. Iwata
GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-producing capacity
Int. Immunol., April 1, 2009; 21(4): 361 - 377.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. P. Levi, O. H. Yilmaz, G. Duester, and S. J. Morrison
Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems
Blood, February 19, 2009; 113(8): 1670 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Safi, G. G. Muramoto, A. B. Salter, S. Meadows, H. Himburg, L. Russell, P. Daher, P. Doan, M. D. Leibowitz, N. J. Chao, et al.
Pharmacological Manipulation of the RAR/RXR Signaling Pathway Maintains the Repopulating Capacity of Hematopoietic Stem Cells in Culture
Mol. Endocrinol., February 1, 2009; 23(2): 188 - 201.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M.-L. Asselin-Labat, F. Vaillant, M. Shackleton, T. Bouras, G.J. Lindeman, and J.E. Visvader
Delineating the Epithelial Hierarchy in the Mouse Mammary Gland
Cold Spring Harb Symp Quant Biol, November 19, 2008; (2008) sqb.2008.73.020v2.
[Abstract] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. Feldmann, V. Fendrich, K. McGovern, D. Bedja, S. Bisht, H. Alvarez, J.-B. M. Koorstra, N. Habbe, C. Karikari, M. Mullendore, et al.
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer
Mol. Cancer Ther., September 1, 2008; 7(9): 2725 - 2735.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. J. Povsic, K. L. Zavodni, F. L. Kelly, S. Zhu, P. J. Goldschmidt-Clermont, C. Dong, and E. D. Peterson
Circulating Progenitor Cells Can Be Reliably Identified on the Basis of Aldehyde Dehydrogenase Activity
J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2243 - 2248.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
O. Christ, K. Lucke, S. Imren, K. Leung, M. Hamilton, A. Eaves, C. Smith, and C. Eaves
Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity
Haematologica, September 1, 2007; 92(9): 1165 - 1172.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Nagano, T. Yamashita, H. Hamada, K. Ohneda, K.-i. Kimura, T. Nakagawa, M. Shibuya, H. Yoshikawa, and O. Ohneda
Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord blood
Blood, July 1, 2007; 110(1): 151 - 160.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Feldmann, S. Dhara, V. Fendrich, D. Bedja, R. Beaty, M. Mullendore, C. Karikari, H. Alvarez, C. Iacobuzio-Donahue, A. Jimeno, et al.
Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers
Cancer Res., March 1, 2007; 67(5): 2187 - 2196.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. P. Chute, G. G. Muramoto, J. Whitesides, M. Colvin, R. Safi, N. J. Chao, and D. P. McDonnell
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells
PNAS, August 1, 2006; 103(31): 11707 - 11712.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. A. Hess, L. Wirthlin, T. P. Craft, P. E. Herrbrich, S. A. Hohm, R. Lahey, W. C. Eades, M. H. Creer, and J. A. Nolta
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells
Blood, March 1, 2006; 107(5): 2162 - 2169.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Corti, F. Locatelli, D. Papadimitriou, C. Donadoni, R. Del Bo, M. Crimi, A. Bordoni, F. Fortunato, S. Strazzer, G. Menozzi, et al.
Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1
Hum. Mol. Genet., January 15, 2006; 15(2): 167 - 187.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Ravandi and Z. Estrov
Eradication of Leukemia Stem Cells as a New Goal of Therapy in Leukemia
Clin. Cancer Res., January 15, 2006; 12(2): 340 - 344.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Locke, M. Heywood, S. Fawell, and I. C. Mackenzie
Retention of Intrinsic Stem Cell Hierarchies in Carcinoma-Derived Cell Lines
Cancer Res., October 1, 2005; 65(19): 8944 - 8950.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. W. Storms, P. D. Green, K. M. Safford, D. Niedzwiecki, C. R. Cogle, O. M. Colvin, N. J. Chao, H. E. Rice, and C. A. Smith
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34
Blood, July 1, 2005; 106(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Vodyanik, J. A. Bork, J. A. Thomson, and I. I. Slukvin
Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential
Blood, January 15, 2005; 105(2): 617 - 626.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020